EXOSAP-IT Trademark

Trademark Overview

On Thursday, November 1, 2001, a trademark application was filed for EXOSAP-IT with the United States Patent and Trademark Office. The USPTO has given the EXOSAP-IT trademark a serial number of 78091188. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, January 17, 2023. This trademark is owned by USB Corporation. The EXOSAP-IT trademark is filed in the Pharmaceutical Products category with the following description:

Chemicals for use in medicine, namely clinical and diagnostic biochemicals in the nature of reagents for DNA sequencing
exosap-it

General Information

Serial Number78091188
Word MarkEXOSAP-IT
Filing DateThursday, November 1, 2001
Status800 - REGISTERED AND RENEWED
Status DateTuesday, January 17, 2023
Registration Number2588652
Registration DateTuesday, July 2, 2002
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 9, 2002

Trademark Statements

Goods and ServicesChemicals for use in medicine, namely clinical and diagnostic biochemicals in the nature of reagents for DNA sequencing

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 7, 2001
Primary Code005
First Use Anywhere DateThursday, July 27, 2000
First Use In Commerce DateThursday, July 27, 2000

Trademark Owner History

Party NameAFFYMETRIX, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSANTA CLARA, CA 95051
Party NameUSB Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCleveland, OH 44128
Party NameUSB Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCleveland, OH 44128
Party NameUSB Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCleveland, OH 44128

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, January 17, 2023REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, January 17, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, January 17, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 30, 2022TEAS SECTION 8 & 9 RECEIVED
Friday, July 2, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 13, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, November 9, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 9, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 24, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 24, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 22, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, February 22, 2012REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, February 22, 2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, February 2, 2012TEAS SECTION 8 & 9 RECEIVED
Wednesday, June 16, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, July 18, 2008REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, July 14, 2008ASSIGNED TO PARALEGAL
Wednesday, July 2, 2008TEAS SECTION 8 & 15 RECEIVED
Friday, September 14, 2007CASE FILE IN TICRS
Friday, September 19, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 2, 2002REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2002PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2002NOTICE OF PUBLICATION
Wednesday, February 6, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 1, 2002NON-FINAL ACTION MAILED
Wednesday, January 30, 2002ASSIGNED TO EXAMINER

Related Keywords

exosap nature reagents sequencing biochemicals diagnostic medicine namely clinical chemicals